首页>
外国专利>
lncRNAs GADLOR 1 AND 2 FOR USE IN TREATING AND PREVENTING CARDIAC REMODELLING
lncRNAs GADLOR 1 AND 2 FOR USE IN TREATING AND PREVENTING CARDIAC REMODELLING
展开▼
机译:lncRNA GADLOR 1和2用于治疗和预防心脏重塑
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a compound inhibiting the expression and/or the activity of a long non-coding RNA (IncRNA) selected from GADLOR 1 and GADLOR 2 for use in treating or preventing cardiac remodelling, wherein GADLOR 1 comprises or consists of a nucleic acid sequence selected from the group consisting of SEQ ID NOs 1 to 3 and sequences being at least 75% identical thereto, and GADLOR 2 comprises or consists of a nucleic acid sequence selected from the group consisting of SEQ ID NOs 4 to 6 and sequences being at least 75% identical thereto.
展开▼
机译:本发明涉及一种抑制选自GADLOR 1和GADLOR 2的长非编码RNA(IncRNA)的表达和/或活性的化合物,其用于治疗或预防心脏重塑,其中GADLOR 1包含或由核酸组成选自SEQ ID NOs 1至3的核酸序列和与其至少75%相同的序列,并且GADLOR 2包含选自SEQ ID NOs 4至6的核酸序列或由其组成的核酸序列或由其组成至少75%相同。
展开▼